ONTARIO, Calif., Sept. 22, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) along with Datavault AI Inc.(Nasdaq: DVLT) and Harrison…
OCALA, Fla., Sept. 22, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that…
#63 pairing of Mortara-Grosjean finish 10th in penultimate round of the year after late cautionSant’Agata Bolognese/Indianapolis, 21 September 2025 –…
SYDNEY, Sept. 22, 2025 /PRNewswire/ -- VT Markets, a leading multi-asset broker, is celebrating the success of its ongoing partnership with…
DUBAI, UAE, Sept. 22, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, today announced it has…
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
19 September 2025 - Today, during the second day of its meeting in Milan, the International Olympic Committee (IOC) Executive Board (EB)…
19 September 2025 - In a world shaken by conflict and division, the International Olympic Committee (IOC) Executive Board (EB) stands firm in…
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to Immediate Edge Immediate Edge is a cutting-edge AI-powered…
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…